Monopar Therapeutics Inc (MNPR) financials · $431.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Monopar Therapeutics Inc (MNPR) $431.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$16.7M | -$16.2M |
| Net Income | -$13.7M | -$15.6M |
| EPS (Diluted) | -$1.85 | -$4.11 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $140.7M | $60.3M |
| Current Assets | $140.5M | $60.3M |
| Cash & Equivalents | $61.8M | $45.8M |
| Total Liabilities | $2.89M | $5.25M |
| Current Liabilities | $2.74M | $5.25M |
| Shareholders' Equity | $137.8M | $55.0M |
| Retained Earnings | -$89.5M | -$75.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$12.2M | -$6.40M |
| Investing Cash Flow | -$63.5M | -$14.3M |
| Financing Cash Flow | $91.6M | $59.3M |
| Net Change in Cash | $16.0M | $38.6M |
FAQ
What is MNPR P/E and revenue?
Monopar Therapeutics Inc (MNPR) $431.4M cap.
What is MNPR revenue?
MNPR income-statement cache has no revenue figure yet.
Is MNPR profitable?
Monopar Therapeutics Inc last cached net income is -$13.7M (FY2025).
What are MNPR total assets?
Monopar Therapeutics Inc last cached total assets are $140.7M (FY2025).
What is MNPR free cash flow?
No cached cash-flow row for MNPR yet.
Not investment advice. Cached statements, not a live tape.